A Phase III, multicenter, double-blind, placebo-controlled study aimed at evaluating the efficacy and safety of induction therapy with RO7790121 in patients suffering from moderately to severely active ulcerative colitis.

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 1bd1e02bfe95c514e3b71278e73ed39ad502be08
First added on: Apr 23, 2026